157 related articles for article (PubMed ID: 20074419)
1. First- and second-line drug resistance patterns among previously treated tuberculosis patients in India.
Paramasivan CN; Rehman F; Wares F; Sundar Mohan N; Sundar S; Devi S; Narayanan PR
Int J Tuberc Lung Dis; 2010 Feb; 14(2):243-6. PubMed ID: 20074419
[TBL] [Abstract][Full Text] [Related]
2. Multidrug- and extensively drug-resistant tuberculosis, Germany.
Eker B; Ortmann J; Migliori GB; Sotgiu G; Muetterlein R; Centis R; Hoffmann H; Kirsten D; Schaberg T; Ruesch-Gerdes S; Lange C;
Emerg Infect Dis; 2008 Nov; 14(11):1700-6. PubMed ID: 18976552
[TBL] [Abstract][Full Text] [Related]
3. Multidrug-resistant and extensively drug-resistant tuberculosis in multi-ethnic region, Xinjiang Uygur Autonomous Region, China.
Qi YC; Ma MJ; Li DJ; Chen MJ; Lu QB; Li XJ; Li JL; Liu W; Cao WC
PLoS One; 2012; 7(2):e32103. PubMed ID: 22384153
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacology and lesion penetrating properties of second- and third-line antituberculous agents used in the management of multidrug-resistant (MDR) and extensively-drug resistant (XDR) tuberculosis.
Dartois V; Barry CE
Curr Clin Pharmacol; 2010 May; 5(2):96-114. PubMed ID: 20156156
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis.
Migliori GB; Sotgiu G; Gandhi NR; Falzon D; DeRiemer K; Centis R; Hollm-Delgado MG; Palmero D; Pérez-Guzmán C; Vargas MH; D'Ambrosio L; Spanevello A; Bauer M; Chan ED; Schaaf HS; Keshavjee S; Holtz TH; Menzies D;
Eur Respir J; 2013 Jul; 42(1):169-179. PubMed ID: 23060633
[TBL] [Abstract][Full Text] [Related]
6. WHO strategies for the programmatic management of drug-resistant tuberculosis.
Matteelli A; Centis R; D'Ambrosio L; Sotgiu G; Tadolini M; Pontali E; Spanevello A; Migliori GB
Expert Rev Respir Med; 2016 Sep; 10(9):991-1002. PubMed ID: 27276361
[TBL] [Abstract][Full Text] [Related]
7. Caveat emptor? Meta-analysis of studies comparing self-observed therapy and directly observed therapy for tuberculosis.
Moonan PK; Weis SE
Clin Infect Dis; 2013 Oct; 57(7):1062-3. PubMed ID: 23811420
[No Abstract] [Full Text] [Related]
8. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.
Sethi S; Mewara A; Dhatwalia SK; Singh H; Yadav R; Singh K; Gupta D; Wanchu A; Sharma M
BMC Infect Dis; 2013 Mar; 13():137. PubMed ID: 23497169
[TBL] [Abstract][Full Text] [Related]
9. Primary and acquired drug resistance patterns of Mycobacterium tuberculosis isolates in India: a multicenter study.
Mathuria JP; Samaria JK; Srivastava GN; Mathuria BL; Ojha SK; Anupurba S
J Infect Public Health; 2013 Dec; 6(6):456-64. PubMed ID: 23999345
[TBL] [Abstract][Full Text] [Related]
10. Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.
Porwal C; Kaushik A; Makkar N; Banavaliker JN; Hanif M; Singla R; Bhatnagar AK; Behera D; Pande JN; Singh UB
PLoS One; 2013; 8(2):e55299. PubMed ID: 23390524
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Genetic Mutations in Multi-Drug-Resistant Isolates of Mycobacterium tuberculosis Bacilli Conferring Resistance to a Second-Line Anti-tuberculosis Drug.
Sharma RK; Kumari U; Kumari N; Kumar R
Cureus; 2023 Jun; 15(6):e40442. PubMed ID: 37456413
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Antibiotic-Resistant Pulmonary Tuberculosis in Bangladesh: A Systematic Review and Meta-Analysis.
Kundu S; Marzan M; Gan SH; Islam MA
Antibiotics (Basel); 2020 Oct; 9(10):. PubMed ID: 33080862
[TBL] [Abstract][Full Text] [Related]
13. Study of the prevalence of Multidrug-Resistant Pulmonary Tuberculosis (MDR-TB) in Western Rajasthan using line probe assay.
Sharma M; Kumar D; Bohra GK; Meena DS; Bhambu SK
J Family Med Prim Care; 2020 Feb; 9(2):1093-1097. PubMed ID: 32318473
[TBL] [Abstract][Full Text] [Related]
14. Second-line Drug Resistance Characterization in
Sethi S; Agarwal P; Khaneja R; Kumar N; Kumar N; Chandna J; Aggarwal AN; Yadav R
J Epidemiol Glob Health; 2020 Mar; 10(1):42-45. PubMed ID: 32175709
[TBL] [Abstract][Full Text] [Related]
15. Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China.
Lu Z; Jiang W; Zhang J; Lynn HS; Chen Y; Zhang S; Ma Z; Geng P; Guo X; Zhang H; Zhang Z
PLoS One; 2019; 14(11):e0225361. PubMed ID: 31751390
[TBL] [Abstract][Full Text] [Related]
16. First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017.
Glasauer S; Altmann D; Hauer B; Brodhun B; Haas W; Perumal N
PLoS One; 2019; 14(6):e0217597. PubMed ID: 31188848
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis.
Goyal V; Kadam V; Narang P; Singh V
BMC Public Health; 2017 Oct; 17(1):817. PubMed ID: 29041901
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Molecular Characterization of Second-Line Drugs Resistance among Multidrug-Resistant
Hu Y; Xu L; He YL; Pang Y; Lu N; Liu J; Shen J; Zhu DM; Feng X; Wang YW; Yang C
Biomed Res Int; 2017; 2017():4563826. PubMed ID: 28798931
[TBL] [Abstract][Full Text] [Related]
19. Frequency of multi-drug resistance and mutations in Mycobacterium tuberculosis isolates from Punjab state of India.
Singhal R; Arora J; Sah GC; Bhalla M; Sarin R; Prasad Myneedu V
J Epidemiol Glob Health; 2017 Sep; 7(3):175-180. PubMed ID: 28756826
[TBL] [Abstract][Full Text] [Related]
20. Extensively drug-resistant tuberculosis in India: Current evidence on diagnosis & management.
Prasad R; Singh A; Balasubramanian V; Gupta N
Indian J Med Res; 2017 Mar; 145(3):271-293. PubMed ID: 28749390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
